IRIS
GIALLONGO, CESARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.150
EU - Europa 4.492
AS - Asia 2.972
AF - Africa 504
SA - Sud America 461
Continente sconosciuto - Info sul continente non disponibili 213
OC - Oceania 6
Totale 14.798
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.952
IT - Italia 1.977
RU - Federazione Russa 1.297
SG - Singapore 1.296
CN - Cina 857
BR - Brasile 372
CI - Costa d'Avorio 331
IE - Irlanda 292
VN - Vietnam 279
FR - Francia 154
KR - Corea 146
UA - Ucraina 142
CA - Canada 128
DE - Germania 117
SE - Svezia 113
GB - Regno Unito 103
BD - Bangladesh 82
IN - India 75
FI - Finlandia 63
NG - Nigeria 52
JP - Giappone 51
SN - Senegal 51
PL - Polonia 48
NL - Olanda 42
MX - Messico 40
HK - Hong Kong 38
AR - Argentina 31
CZ - Repubblica Ceca 27
ES - Italia 27
IQ - Iraq 23
ZA - Sudafrica 19
CH - Svizzera 18
EC - Ecuador 17
BE - Belgio 16
BJ - Benin 16
TR - Turchia 15
LB - Libano 11
AE - Emirati Arabi Uniti 10
ID - Indonesia 10
CL - Cile 9
IL - Israele 9
MA - Marocco 9
UZ - Uzbekistan 9
CO - Colombia 8
CR - Costa Rica 8
GR - Grecia 8
KE - Kenya 8
LT - Lituania 8
NP - Nepal 7
PK - Pakistan 7
PY - Paraguay 7
AT - Austria 6
JO - Giordania 6
TN - Tunisia 6
VE - Venezuela 6
AU - Australia 5
IR - Iran 5
NI - Nicaragua 5
PH - Filippine 5
SA - Arabia Saudita 5
AL - Albania 4
EG - Egitto 4
ET - Etiopia 4
HR - Croazia 4
JM - Giamaica 4
NO - Norvegia 4
RO - Romania 4
SI - Slovenia 4
BO - Bolivia 3
GT - Guatemala 3
KZ - Kazakistan 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
DZ - Algeria 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
MT - Malta 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SR - Suriname 2
AM - Armenia 1
BF - Burkina Faso 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
KW - Kuwait 1
Totale 14.579
Salva come PNG Salva come JPEG
Città #
Dallas 1.296
Singapore 873
Santa Clara 677
Moscow 654
Catania 510
San Jose 457
Chandler 453
Ashburn 354
Abidjan 330
Chicago 298
Dublin 286
Hefei 227
Beijing 160
Jacksonville 159
Los Angeles 156
Seoul 139
Council Bluffs 136
Boardman 123
Lauterbourg 93
New York 92
Civitanova Marche 91
Florence 86
Houston 85
Rome 85
Ho Chi Minh City 78
Palermo 75
Milan 70
Lawrence 69
Cambridge 68
Andover 64
Buffalo 54
Toronto 52
Dakar 51
Hanoi 50
São Paulo 50
Dong Ket 44
Warsaw 44
Munich 43
Nanjing 42
Des Moines 36
Messina 35
Hong Kong 34
Tokyo 34
Orem 30
Bari 29
Abuja 28
Montreal 28
Bronte 26
Misterbianco 26
Bremen 25
Brooklyn 24
Helsinki 24
Wilmington 24
Amsterdam 23
Lagos 23
Lappeenranta 23
London 23
Paris 22
Phoenix 22
Boston 21
Chennai 21
Denver 21
Naples 21
The Dalles 20
Brno 19
Saint Petersburg 19
San Mateo 19
Stockholm 19
Washington 19
Acireale 18
Falls Church 18
Nanchang 18
Poplar 18
Turin 18
Atlanta 17
Shenyang 17
Columbus 16
Cotonou 16
Mascalucia 16
Turku 16
Manchester 15
San Giovanni la Punta 15
Seattle 15
Brussels 14
Charlotte 14
Dearborn 14
Fukuoka 14
Johannesburg 14
Mexico City 14
Mumbai 14
Augusta 13
San Francisco 13
Hebei 12
Kochi 12
Ottawa 12
Guangzhou 11
Piscataway 11
Changsha 10
Haiphong 10
Aci Catena 9
Totale 9.856
Salva come PNG Salva come JPEG
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 283
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 245
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 236
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 230
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 222
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 220
Biological properties of itraconazole-SLN 218
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance 216
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 209
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 204
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 204
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing 202
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 201
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 199
Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation 194
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 193
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells 191
Focus on Osteosclerotic Progression in Primary Myelofibrosis 189
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib 184
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 183
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 183
Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients 176
Biological properties of itraconazole-SLNs 173
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 169
Hedgehog signaling pathways in multiple myeloma 169
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 168
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models 166
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 166
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 165
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 163
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 162
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 162
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma 161
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 161
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 158
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 156
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 154
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 154
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 151
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 150
Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG 149
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 149
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 149
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 147
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 147
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 146
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype 145
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 145
Correction to: Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models (Antioxidants, (2022), 11, 8, (1596), 10.3390/antiox11081596) 144
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 144
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 143
Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells 142
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 141
Rebalancing Immune Interactions within the Brain-Spleen Axis Mitigates Neuroinflammation in an Aging Mouse Model of Alzheimer’s Disease 136
The Role of Epigenetics in Neuroinflammatory-Driven Diseases 135
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 135
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 132
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 132
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 132
Pericytes in microvessels: From “mural” function to brain and retina regeneration 132
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 131
Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project 131
The Heme Oxygenase System in Hematological Malignancies 130
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 129
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 129
Correction to: Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 127
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 127
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 124
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 122
Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors 121
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells 118
Myeloid-derived suppressor cells in Chronic myeloid leukemia 117
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 114
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 114
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 113
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 113
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 109
Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture 107
Effects of imatinib mesylate in osteoblastogenesis 104
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 103
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 100
Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity 94
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 91
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION 90
OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE 90
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Corneal Epithelial Cells against UV-B-Induced Apoptosis via ROS/JNK Pathway Inhibition 90
GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS 88
The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms 85
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. 83
Uveal melanoma cells elicit retinal pericyte phenotypical and biochemical changes in an in vitro model of coculture 82
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome 81
Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients 81
Proteasome inhibitors as a possible therapy for SARS-CoV-2 80
IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA 79
LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS 77
Mesenchymal Stromal Cells (MSC) As Key Players in the Tumor Microenvironment Transformation from MGUS to Myeloma 77
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells 76
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients 76
Monocytic myeloid derived suppressor cells in hematological malignancies 75
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC) 73
Totale 14.366
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022535 0 0 10 4 116 26 101 49 51 31 18 129
2022/20231.368 96 112 40 144 111 188 19 237 267 44 71 39
2023/2024928 55 140 39 40 47 203 40 88 4 25 168 79
2024/20252.886 42 456 155 198 522 357 157 136 175 226 242 220
2025/20267.310 417 883 1.051 479 950 1.536 581 175 378 441 246 173
2026/2027524 198 269 57 0 0 0 0 0 0 0 0 0
Totale 14.798